F. Castro-Peralta

发表

La Piedad Michoacán Mexico Virus V protein antagonizes type I interferon response by binding STAT2 protein and preventing STATs nuclear translocation.

A. García-Sastre, B. Manicassamy, G. Iovane, 2016, Virus research.

Safety and immunogenicity of a live recombinant Newcastle disease virus-based COVID-19 vaccine (Patria) administered via the intramuscular or intranasal route: Interim results of a non-randomized open label phase I trial in Mexico

A. García-Sastre, P. Palese, I. González-Domínguez, 2022, medRxiv.

Safety and Immunogenicity of a Newcastle Disease Virus Vector-Based SARS-CoV-2 Vaccine Candidate, AVX/COVID-12-HEXAPRO (Patria), in Pigs

A. García-Sastre, P. Palese, F. Krammer, 2021, mBio.

The use of oligonucleotide directed cleavage of DNA and homologous recombination in the production of large recombinant adenoviral vectors

L. Villarreal, F. Castro-Peralta, 2000, Gene Therapy.

Protective Dose of a Recombinant Newcastle Disease LaSota–Avian Influenza Virus H5 Vaccine Against H5N2 Highly Pathogenic Avian Influenza Virus and Velogenic Viscerotropic Newcastle Disease Virus in Broilers with High Maternal Antibody Levels

E. Loza-Rubio, R. Flores-Castro, B. Lozano-Dubernard, 2010, Avian diseases.

Origins of the 2009 H1N1 influenza pandemic in swine in Mexico

Andrew Rambaut, Martha I Nelson, Adolfo García-Sastre, 2016, eLife.

Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico

A. García-Sastre, P. Palese, I. González-Domínguez, 2023, NPJ vaccines.

Protection and Differentiation of Infected from Vaccinated Animals by an Inactivated Recombinant Newcastle Disease Virus/Avian Influenza H5 Vaccine

E. Loza-Rubio, R. Flores-Castro, B. Lozano-Dubernard, 2010, Avian diseases.